Table 1.
Reference | Rationale | Methodology | Outcomes | Results |
---|---|---|---|---|
[1] | Low-dose aspirin eligibility. | Mathematical modeling. | Minimum control event rate. Minimum event rate for treatment. Threshold number needed to treat. |
Moderately-elevated-risk patients are eligible for low-dose aspirin. |
[2] | Management guidelines. | - | - | Synopsis of the 2014 Australia and New Zealand PE-E management guidelines. |
[3] | Congo red dot (CRD) urine test is a rapid, affordable diagnostic test. | Prospective cohort. | First, second, and third trimester PE detection. | In the first trimester CRD used alone detects 33.3%, 16.1%, and 20% of early, late, and all PE cases. |
[5] | Contextualizes significance of fullPIERS. | - | - | fullPIERS offers PE-E prediction. |
[6] | Historic context for maternal severe hypertension care bundle development. | Review article. | Vital signs changes. Systolic blood pressure (SBP), diastolic blood pressure (DBP). | Eclampsia alarm criteria: increases from pregnancy baseline––doubled maternal pulse pressure, SBP by 64 ± 12 mm Hg, or DBP by 31 ± 10 mm Hg. |
[7] | Historical context. | - | - | Defined early- and late-onset PE-E. |
[9] | California pregnancy-related deaths, 2002–2005. In the US in 1997, maternal mortality rate was 7.7/100,000 live births. By 2009 the rate increased to 17.8/100,000. | Retrospective cohort. | Leading causes of maternal mortality. | Cardiovascular disease, PE-E, hemorrhage, venous thromboembolism, and amniotic fluid embolism accounted for 143 of 207 pregnancy-related maternal deaths from 2002–2005. |
[13] | Relevance of continuous quality improvement in women’s healthcare. | - | - | Work with precursors, processes, and indicators to deliver better population health and better healthcare at lower cost. |
[14] | Combined antepartum low-dose aspirin and heparin. | Systematic review and meta-analysis. | Incidence of PE, severe PE, early-onset PE, and small for gestational age (SGA) fetuses. | In early-onset PE, low molecular weight heparin in combination with low-dose aspirin offers further reduction of PE and SGA fetuses than use of low-dose aspirin alone. |
[16] | Anticonvulsant efficacy for PE-E. | Systematic review of randomized trials of anticonvulsants with or without a placebo control group. | Eclampsia prevention. There was insufficient evidence to compare magnesium sulfate to diazepam, isosorbide, or methyldopa. | Risk of eclampsia is halved by magnesium sulfate, which is more effective than phenytoin and nimodipine. However, magnesium sulfate increases the risk of cesarean delivery when compared to phenytoin. |
[18] | Preeclampsia admitting diagnosis patients at a single-tertiary perinatal unit. | 24 month pre- and 41 month post-intervention cohort comparison. Intervention was a standardized surveillance protocol. | Any of 17 adverse maternal outcomes and any of seven adverse perinatal or infant outcomes. | Adverse maternal outcomes fell from 5.1% to 0.7%, Fisher p < 0.001, odds ratio 0.14, 95% confidence interval 0.04–0.49. Unchanged perinatal outcomes. |
[28] | Medical management of severe hypertension | - | - | Severe hypertension treatment protocol. |